Equities

Indivior PLC

INDV:LSE

Indivior PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)1,352.00
  • Today's Change-33.00 / -2.38%
  • Shares traded542.07k
  • 1 Year change-7.78%
  • Beta-0.2307
Data delayed at least 20 minutes, as of May 16 2024 16:49 BST.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments4108931,102
Total Receivables, Net254225215
Total Inventory14211495
Prepaid expenses231418
Other current assets, total4341314
Total current assets1,2631,2591,444
Property, plant & equipment, net1178595
Goodwill, net------
Intangibles, net2377082
Long term investments4198--
Note receivable - long term9.001884
Other long term assets------
Total assets1,9541,7691,832
LIABILITIES
Accounts payable6736137
Accrued expenses676581583
Notes payable/short-term debt000
Current portion long-term debt/capital leases121111
Other current liabilities, total55039173
Total current liabilities1,3051,019804
Total long term debt270266275
Total debt282277286
Deferred income tax------
Minority interest------
Other liabilities, total379433550
Total liabilities1,9541,7181,629
SHAREHOLDERS EQUITY
Common stock686870
Additional paid-in capital118.007.00
Retained earnings (accumulated deficit)(44)14146
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(35)(39)(20)
Total equity051203
Total liabilities & shareholders' equity1,9541,7691,832
Total common shares outstanding137136140
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.